Publications by authors named "Junchang Cui"

Claim this Profile
C
Clinical risk factors, antimicrobial therapy, and virulence-associated mortality in patients with extensively drug-resistant or pan-drug-resistant (XDR/PDR) Pseudomonas aeruginosa pulmonary infections.
Yixin Kang, Zihan Zhang, Junchang Cui

Int J Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and comparison of -induced resistant and clinically resistant strains for eravacycline resistance-related genes.
Jie Wu, Jiarong Song, Junchang Cui

Front Cell Infect Microbiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic target attainment of the synergism of ceftazidime-avibactam in combination with amikacin against OXA-producing extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa.
Yixin Kang, Junchang Cui

Eur J Clin Microbiol Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of OXA-101 and OXA-573 in Extensively Drug-Resistant/ Pan Drug-Resistant (XDR/PDR) Resistance to Ceftazidime-Avibactam.
Yixin Kang, Junchang Cui

Infect Drug Resist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Hospitalized Immunocompromised Patients With COVID-19 and the Impact of Hyperinflammation: A Retrospective Cohort Study.
Xinxin Zhang, Xiaobo Han, Chenglong Li, Junchang Cui, Xin Yuan

J Inflamm Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China: a multicentre, retrospective cohort study.
Xiaobo Han, Chenglong Li, Xin Yuan, Junchang Cui, Zhihai Han

Ann Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study.
Xiaobo Han, Darui Gao, Chenglong Li, Xin Yuan, Junchang Cui

BMC Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant .
Jie Wu, Guangcun Zhang, Qiang Zhao, Lifeng Wang, Jiyong Yang, Junchang Cui

Infect Drug Resist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) .
Yixin Kang, Lu Xie, Jiyong Yang, Junchang Cui

Front Cell Infect Microbiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Efficacy of Optimized Two-Step-Administration Therapy with Ceftazidime/Avibactam for Treating Extensively Drug-Resistant Pseudomonas aeruginosa Pulmonary Infections: a Pharmacokinetic/Pharmacodynamic Analysis.
Yixin Kang, Junchang Cui

Jpn J Infect Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker.
Yixin Kang, Cheng Ge, Huan Zhang, Saizhe Liu, Hongyang Guo, Junchang Cui

Infect Drug Resist· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China.
Yixin Kang, Qian Zhou, Junchang Cui

J Glob Antimicrob Resist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
Fangzhou Wang, Qian Zhou, Xiuwen Yang, Yan Bai, Junchang Cui

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
Wentao Ni, Deqing Yang, Jie Guan, Wen Xi, Dexun Zhou, Junchang Cui

J Antimicrob Chemother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
Wentao Ni, Guobao Li, Jin Zhao, Junchang Cui, Rui Wang

Infect Dis (Lond)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Ni Wentao, Li Guobao, Zhao Jin, Cui Junchang, Wang Rui

J Antibiot (Tokyo)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Xuejiu Cai, Zhen Yang, Jianqiang Dai, Kun Chen, Liangda Zhang, Junchang Cui

Int J Antimicrob Agents· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
Wentao Ni, Deqing Yang, Hekun Mei, Jin Zhao, Beibei Liang, Junchang Cui

Antimicrob Agents Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.
Wentao Ni, Yuliang Han, Jin Zhao, Junchang Cui, Kai Wang

Sci Rep· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae.
Wentao Ni, Chuanqi Wei, Chufei Zhou, Jin Zhao, Beibei Liang, Junchang Cui

Front Microbiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Chuanqi Wei, Wentao Ni, Xuejiu Cai, Jin Zhao, Junchang Cui

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria.
Wentao Ni, Yanjun Li, Jie Guan, Jin Zhao, Junchang Cui

Antimicrob Agents Chemother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis.
Wentao Ni, Yuliang Han, Jie Liu, Chuanqi Wei, Jin Zhao, Junchang Cui

Medicine (Baltimore)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.
Wentao Ni, Yuliang Han, Jin Zhao, Chuanqi Wei, Junchang Cui

Int J Antimicrob Agents· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years.
Fei Qi, Guo-Xin Zhang, Dan-Yang She, Zhi-Xin Liang, Ren-Tao Wang, Jun-Chang Cui

Chin Med J (Engl)· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis